John Hussman's GILD Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 14,700 shares of Gilead Sciences, Inc. (GILD) worth $1.8 M, representing 0.44% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 33 quarters.
Based on 13F filings, John Hussman has maintained a strategic position in GILD, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2015, adding 75,000 shares. Largest reduction occurred in Q4 2013, reducing 250,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Gilead Sciences (GILD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Gilead Sciences (GILD) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +350,001 | Add 0.00% | 350,000 | $51.21 |
| Q3 2013 | -100,000 | Reduce 28.57% | 250,000 | $62.84 |
| Q4 2013 | -250,000 | Sold Out | 0 | $0.00 |
| Q2 2015 | +75,000 | New Buy | 75,000 | $117.08 |
| Q4 2015 | -75,000 | Sold Out | 0 | $0.00 |
| Q1 2017 | +50,000 | New Buy | 50,000 | $67.92 |
| Q2 2017 | -25,000 | Reduce 50.00% | 25,000 | $70.76 |
| Q3 2017 | -25,000 | Sold Out | 0 | $0.00 |
| Q1 2018 | +50,800 | New Buy | 50,800 | $75.39 |
| Q3 2018 | -25,000 | Reduce 49.21% | 25,800 | $77.21 |
| Q4 2018 | -25,000 | Reduce 96.90% | 800 | $62.50 |
| Q1 2019 | -800 | Sold Out | 0 | $0.00 |
| Q1 2020 | +41,150 | New Buy | 41,150 | $74.75 |
| Q2 2020 | -41,150 | Sold Out | 0 | $0.00 |
| Q4 2020 | +20,400 | New Buy | 20,400 | $58.24 |
| Q1 2021 | -20,400 | Sold Out | 0 | $0.00 |
| Q4 2021 | +31,200 | New Buy | 31,200 | $72.60 |
| Q4 2022 | -6,400 | Reduce 20.51% | 24,800 | $85.85 |
| Q2 2023 | +12,800 | Add 51.61% | 37,600 | $77.07 |
| Q3 2023 | +4,400 | Add 11.70% | 42,000 | $74.94 |
| Q3 2024 | -42,000 | Sold Out | 0 | $0.00 |
| Q2 2025 | +21,000 | New Buy | 21,000 | $110.87 |
| Q4 2025 | -6,300 | Reduce 30.00% | 14,700 | $122.74 |
John Hussman's Gilead Sciences Investment FAQs
John Hussman first purchased Gilead Sciences, Inc. (GILD) in Q2 2013, acquiring 350,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Gilead Sciences, Inc. (GILD) for 33 quarters since Q2 2013.
John Hussman's largest addition to Gilead Sciences, Inc. (GILD) was in Q2 2013, adding 350,000 shares worth $17.92 M.
According to the latest 13F filing for Q4 2025, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 14,700 shares of Gilead Sciences, Inc. (GILD), valued at approximately $1.8 M.
As of the Q4 2025 filing, Gilead Sciences, Inc. (GILD) represents approximately 0.44% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Gilead Sciences, Inc. (GILD) was 350,000 shares, as reported at the end of Q2 2013.